Press Releases
Latin America’s largest medical diagnostic company taps into SOPHiA GENETICS’ new multimodal solution to fight cancer, fostering a new Data-Driven Medicine era
São Paulo, Brazil, July 23, 2020: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today...
SOPHiA GENETICS expands its executive team, naming Lara Hashimoto Chief Business Officer
Lausanne, Switzerland, and Boston, United States, April 8, 2020: SOPHiA GENETICS, leader in...
SOPHiA GENETICS and Paragon Genomics join forces against the COVID-19 coronavirus pandemic
Lausanne, Switzerland, and Boston, United States, March 26, 2020: SOPHiA GENETICS, leader in...
MGI and SOPHiA GENETICS partner to provide solutions to interpret genomic data
SAN JOSE, CA, Feb. 27, 2020 – MGI, part of the global genomics leader BGI Group, announced an...
Twist Bioscience and SOPHiA GENETICS collaborate to offer optimized genomic solutions
SOUTH SAN FRANCISCO, CA, Feb. 26, 2020 - Twist Bioscience Corporation (NASDAQ: TWST), a...
SOPHiA GENETICS’ board of directors elects Troy Cox as new Chairman
Lausanne, Switzerland, and Boston, United States – February 20, 2020: SOPHiA GENETICS, leader...
SOPHiA GENETICS appoints Chief Medical Officer to accelerate the execution of medical strategy
Lausanne, Switzerland, and Boston, United States – February 13, 2020: SOPHiA GENETICS,...
IDT partners with SOPHiA GENETICS to increase access to clinical-grade technologies
Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and...
SOPHiA GENETICS welcomes Milton Silva-Craig to its board of directors
Boston, MA, US & Lausanne, Switzerland, November 20, 2019: SOPHiA GENETICS, leader in...
SOPHiA GENETICS reaches new analytical heights with its Whole Exome Solution
SOPHiA Whole Exome Solution (WES) now includes accurate CNV detection, making it a powerful...
SOPHiA GENETICS expands executive team with a Chief Marketing Officer and new Chief Information Officer
Lausanne, Switzerland, and Boston, United States, September 19, 2019: SOPHiA GENETICS, leader...
ADC Therapeutics and SOPHiA GENETICS partner for biomarker discovery in pivotal Phase II clinical trial
Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab...
